Rapt Therapeutics, Inc.

This study tested whether adding the experimental drug RPT193 to standard asthma inhalers could help adults whose asthma isn't fully controlled. Participants had moderate-to-severe asthma and continued using their regular inhalers while receiving either RPT193 or a placebo for 14…

This study tested whether a daily oral pill called RPT193 could reduce the severity of moderate-to-severe eczema (atopic dermatitis) in adults. It compared the drug to a placebo over 16 weeks to see if it improved skin symptoms and was safe. The trial has been terminated, meaning…